The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...

Nearly 3.5 billion people worldwide suffer from oral diseases, yet 90% of these conditions are entirely preventable through proper daily care. What’s particularly striking is that tooth decay remains ...